AA, D., HL, K., D, T., E, A., S, M., K, W., . . . EE, V. (2005). Modulation of irinotecan with cyclosporine: A phase II trial in advanced colorectal cancer. Cancer chemotherapy and pharmacology, 56(4), 421. https://doi.org/10.1007/s00280-005-1020-5
Chicago Style (17th ed.) CitationAA, Desai, Kindler HL, Taber D, Agamah E, Mani S, Wade-Oliver K, Ratain MJ, and Vokes EE. "Modulation of Irinotecan with Cyclosporine: A Phase II Trial in Advanced Colorectal Cancer." Cancer Chemotherapy and Pharmacology 56, no. 4 (2005): 421. https://doi.org/10.1007/s00280-005-1020-5.
MLA (9th ed.) CitationAA, Desai, et al. "Modulation of Irinotecan with Cyclosporine: A Phase II Trial in Advanced Colorectal Cancer." Cancer Chemotherapy and Pharmacology, vol. 56, no. 4, 2005, p. 421, https://doi.org/10.1007/s00280-005-1020-5.